Cargando…

Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of KRAS

SIMPLE SUMMARY: Pancreatic cancer is among the most lethal cancers. The expression of PLEXIND1, a receptor, is upregulated in many cancers (including pancreatic cancer). Traditionally, PLEXIND1 is known to be involved in neuron development and mediate semaphorin signaling. However, its role and sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vivekanandhan, Sneha, Madamsetty, Vijay S., Angom, Ramcharan Singh, Dutta, Shamit Kumar, Wang, Enfeng, Caulfield, Thomas, Pletnev, Alexandre A., Upstill-Goddard, Rosanna, Asmann, Yan W., Chang, David, Spaller, Mark R., Mukhopadhyay, Debabrata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393884/ https://www.ncbi.nlm.nih.gov/pubmed/34439202 http://dx.doi.org/10.3390/cancers13164048

Ejemplares similares

Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer
por: Pal, Krishnendu, et al.
Publicado: (2019)

Vascular Endothelial Growth Factor Receptor-1 Modulates Hypoxia-Mediated Endothelial Senescence and Cellular Membrane Stiffness via YAP-1 Pathways
por: Angom, Ramcharan Singh, et al.
Publicado: (2022)

Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer
por: Madamsetty, Vijay Sagar, et al.
Publicado: (2020)

Genetic status of KRAS modulates the role of Neuropilin-1 in tumorigenesis
por: Vivekanandhan, Sneha, et al.
Publicado: (2017)

LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells
por: Angom, Ramcharan Singh, et al.
Publicado: (2021)

Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC
por: Pal, Krishnendu, et al.
Publicado: (2019)

VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma
por: Sinha, Sutapa, et al.
Publicado: (2010)

Dissecting VEGF-induced acute versus chronic vascular hyperpermeability: Essential roles of dimethylarginine dimethylaminohydrolase-1
por: Wang, Ying, et al.
Publicado: (2021)

The neurotransmitter dopamine modulates vascular permeability in the endothelium
por: Bhattacharya, Resham, et al.
Publicado: (2008)

GAIP Interacting Protein C-Terminus Regulates Autophagy and Exosome Biogenesis of Pancreatic Cancer through Metabolic Pathways
por: Bhattacharya, Santanu, et al.
Publicado: (2014)

GIPC proteins negatively modulate Plexind1 signaling during vascular development
por: Carretero-Ortega, Jorge, et al.
Publicado: (2019)

Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
por: Espindola-Netto, Jair Machado, et al.
Publicado: (2017)

PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells
por: Rehman, Michael, et al.
Publicado: (2016)

Endothelial PlexinD1 signaling instructs spinal cord vascularization and motor neuron development
por: Vieira, José Ricardo, et al.
Publicado: (2022)

Correction: PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells
Publicado: (2016)

Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis
por: Yang, Wan-Jen, et al.
Publicado: (2015)

Structure analyses reveal a regulated oligomerization mechanism of the PlexinD1/GIPC/myosin VI complex
por: Shang, Guijun, et al.
Publicado: (2017)

PlexinD1 signaling controls domain-specific dendritic development in newborn neurons in the postnatal olfactory bulb
por: Sawada, Masato, et al.
Publicado: (2023)

Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo
por: Khan, Jameel Ahmad, et al.
Publicado: (2011)

New functions of Semaphorin 3E and its receptor PlexinD1 during developing and adult hippocampal formation
por: Mata, Agata, et al.
Publicado: (2018)

Advances in Glioblastoma Therapy: An Update on Current Approaches
por: Angom, Ramcharan Singh, et al.
Publicado: (2023)

Semaphorin3E-PlexinD1 signaling in coronary artery and lymphatic vessel development with clinical implications in myocardial recovery
por: Maruyama, Kazuaki, et al.
Publicado: (2021)

Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*
por: Bhattacharya, Resham, et al.
Publicado: (2008)

KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
por: Yu, Shuang-Ni, et al.
Publicado: (2016)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
por: Gurreri, Enrico, et al.
Publicado: (2023)

Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes
por: Nandy, Debashis, et al.
Publicado: (2010)

Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype
por: Fu, Yong, et al.
Publicado: (2015)

Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
por: Liu, Yu-Huei, et al.
Publicado: (2022)

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
por: Zhang, Zining, et al.
Publicado: (2023)

Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2023)

Neuropilin-1 Modulates p53/Caspases Axis to Promote Endothelial Cell Survival
por: Wang, Ling, et al.
Publicado: (2007)

Notch1 Is Not Required for Acinar-to-Ductal Metaplasia in a Model of Kras-Induced Pancreatic Ductal Adenocarcinoma
por: Avila, Jacqueline L., et al.
Publicado: (2012)

An image-based RNAi screen identifies SH3BP1 as a key effector of Semaphorin 3E–PlexinD1 signaling
por: Tata, Aleksandra, et al.
Publicado: (2014)

Support Vector Machine Classifier for Estrogen Receptor Positive and Negative Early-Onset Breast Cancer
por: Upstill-Goddard, Rosanna, et al.
Publicado: (2013)

KRAS mutation analysis in ductal carcinoma of the pancreas; prognostic implications in elderly patients
por: Oldani, Alberto, et al.
Publicado: (2013)

Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks
por: Perkhofer, Lukas, et al.
Publicado: (2019)

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
por: Luchini, Claudio, et al.
Publicado: (2020)

Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma
por: Ashok Kumar, Prashanth, et al.
Publicado: (2023)

Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS(G12D)-driven Pancreatic Tumorigenesis
por: Chuvin, Nicolas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_054mhsgo3ro6v9adnqr0id3gt3